instituteSchepens Eye Research Institute
The research programs of the Schepens Eye Research Institute include both basic and clinical studies focused in several areas: biology of the retina and its diseases; ocular surface diseases; immunity, inflammation and transplantation; vision and visual optics; and ocular gene therapy.
Affiliation: Teaching hospitalsWeb site: http://www.eri.harvard.edu/
Recent articles about Schepens Eye Research Institute
NIH awards Harvard Medical School $117.5 million, five-year grant for patient-centered research (May 29, 2008)Gene responsible for statin-induced muscle pain identified (November 27, 2007)
Schepens scientists first to discover angiogenesis switch inside blood vessel cells (Schepens Eye Research Institute, May 18, 2006)
Barrier found to nerve regeneration (Focus, October 28, 2005)
Dietary fat intake linked to dry eye syndrome in women (Brigham and Women, October 19, 2005)
Schepens scientists regenerate optic nerve for the first time (The Schepens Eye Research Institute, February 23, 2005)
Study finds neural stem cells are not rejected when transplanted (The Schepens Eye Research Institute, July 14, 2003)
Researchers eye earliest triggers of age-related macular degeneration (Focus, February 8, 2002)
A familiar drug gives surprising hope against diabetic blindness (Focus, June 22, 2001)
Sights set on partial corneal transplants (Focus, September 15, 2000)
